// App-Quantinova.ai

761 : Review of efficacy and safety of the new oral anticoagulants (NOACS) in the treatment of venous thromboembolism in gastrointestinal (GI) oncology patients.

Researchers

Presenter

  • Hitendra Patel

Principal Investigators

  • Reem Diri

  • Ahmed Aljabri

  • Christopher Jon Campen

  • Emad Elquza

  • Steve Malangone

  • Ivo Abraham

  • Ali McBride

Medical Centers

  • Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ

  • University of Arizona Cancer Center, Tucson, AZ

  • Center for Health Outcomes and PharmacoEconomic Research, University of Arizona, Tucson, AZ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Gastric Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved